The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior.
Pitchot W, Ansseau M, Gonzalez Moreno A, Lembreghts M, Hansenne M, Wauthy J, Reel C, Jammaer R, Papart P, Sulon J, et al.
Pitchot W, et al.
Pharmacopsychiatry. 1995 Oct;28 Suppl 2:91-2. doi: 10.1055/s-2007-979625.
Pharmacopsychiatry. 1995.
PMID: 8614706
Free article.
Clinical Trial.